ES8900253A1 - Un procedimiento para la preparacion de derivados de piperazinilo 1,4disustituidos - Google Patents

Un procedimiento para la preparacion de derivados de piperazinilo 1,4disustituidos

Info

Publication number
ES8900253A1
ES8900253A1 ES557855A ES557855A ES8900253A1 ES 8900253 A1 ES8900253 A1 ES 8900253A1 ES 557855 A ES557855 A ES 557855A ES 557855 A ES557855 A ES 557855A ES 8900253 A1 ES8900253 A1 ES 8900253A1
Authority
ES
Spain
Prior art keywords
present
hydrocyclic
substitute
formula
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES557855A
Other languages
English (en)
Other versions
ES557855A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ES557855A0 publication Critical patent/ES557855A0/es
Publication of ES8900253A1 publication Critical patent/ES8900253A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE DESCRIBEN EN LA PRESENTE INVENCION DERIVADOS DE PIPERACINILO 1, 4-DISUSTITUIDOS DE FORMULA I, ASI COMO SUS SALES DE ADICION DE ACIDO FARMACEUTICAMENTE ACEPTABLES; EN LOS QUE UN SUSTITUYENTE ES UN HETEROCICLICO DE ANILLOFUSIONADO BICICLICO DE FURO-, PIRROLO-, CILCOPENTADIENO-, O TIENO-PIRIDINA, Y EL SEGUNDO SUSTITUYENTE ES UNA CADENA DE ALQUILENO UNIDA A HETEROCICLICOS DE IMIDIDA CICLICA O UNA PARTE CARBINOL BENCILICA. LOS COMPUESTOS DE LA PRESENTE INVENCION SON AGENTES FARMACOLOGICOS UTILES CON PROPIEDADES PSICOTROPICAS; Y PRESENTAN ACTIVIDAD SELECTIVA SOBRE EL SISTEMA NERVIOSO CENTRAL, SIENDO DE PARTICULAR INTERES COMO AGENTES ANTIPSICOTICOS. *FORMULA*
ES557855A 1985-05-06 1988-11-16 Un procedimiento para la preparacion de derivados de piperazinilo 1,4disustituidos Expired ES8900253A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73120185A 1985-05-06 1985-05-06

Publications (2)

Publication Number Publication Date
ES557855A0 ES557855A0 (es) 1989-05-16
ES8900253A1 true ES8900253A1 (es) 1989-05-16

Family

ID=24938510

Family Applications (6)

Application Number Title Priority Date Filing Date
ES554659A Expired ES8801250A1 (es) 1985-05-06 1986-05-05 Un procedimiento para la preparacion de derivados de piperazimilo 1,4-di sustituidos.
ES557757A Expired ES8802149A1 (es) 1985-05-06 1987-09-25 Un procedimiento para la preparacion de derivados de piperazinilo 1,4-disustituidos
ES557809A Expired ES8802614A1 (es) 1985-05-06 1988-01-28 Un procedimiento para la preparacion de derivados de piperazinilo 1,4 disustituidos
ES557839A Expired ES8900138A1 (es) 1985-05-06 1988-05-26 Un procedimiento para la preparacion de derivados de piperazinilo 1-4-disustituidos.
ES557855A Expired ES8900253A1 (es) 1985-05-06 1988-11-16 Un procedimiento para la preparacion de derivados de piperazinilo 1,4disustituidos
ES557865A Expired ES9000005A1 (es) 1985-05-06 1989-02-27 Un procedimiento para la preparacion de derivados de piperazinilo 1,4-disustituidos

Family Applications Before (4)

Application Number Title Priority Date Filing Date
ES554659A Expired ES8801250A1 (es) 1985-05-06 1986-05-05 Un procedimiento para la preparacion de derivados de piperazimilo 1,4-di sustituidos.
ES557757A Expired ES8802149A1 (es) 1985-05-06 1987-09-25 Un procedimiento para la preparacion de derivados de piperazinilo 1,4-disustituidos
ES557809A Expired ES8802614A1 (es) 1985-05-06 1988-01-28 Un procedimiento para la preparacion de derivados de piperazinilo 1,4 disustituidos
ES557839A Expired ES8900138A1 (es) 1985-05-06 1988-05-26 Un procedimiento para la preparacion de derivados de piperazinilo 1-4-disustituidos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557865A Expired ES9000005A1 (es) 1985-05-06 1989-02-27 Un procedimiento para la preparacion de derivados de piperazinilo 1,4-disustituidos

Country Status (25)

Country Link
JP (1) JPH0753728B2 (es)
KR (1) KR940000829B1 (es)
CN (1) CN1017901B (es)
AT (1) AT398572B (es)
AU (1) AU593244B2 (es)
BE (1) BE904724A (es)
CA (1) CA1278792C (es)
CH (1) CH672787A5 (es)
DE (1) DE3615180C2 (es)
DK (1) DK165745C (es)
EG (1) EG18206A (es)
ES (6) ES8801250A1 (es)
FI (1) FI85484C (es)
FR (1) FR2581385B1 (es)
GB (1) GB2174703B (es)
GR (1) GR861149B (es)
HU (1) HU195509B (es)
IE (1) IE59201B1 (es)
IT (1) IT1208607B (es)
LU (1) LU86421A1 (es)
MY (1) MY100777A (es)
NL (1) NL8601146A (es)
PT (1) PT82523B (es)
SE (1) SE465270B (es)
ZA (1) ZA862046B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801186A (en) * 1987-11-20 1998-09-01 Hoechst Marion Roussel, Inc. 3- 4-(1-substituted-4-piperazinyl)butyl!-4-thiazolidinone and related compounds
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives
US4780466A (en) * 1988-03-17 1988-10-25 Hoechst-Roussel Pharmaceuticals, Inc. Arylpiperazinylalkoxy derivatives of cyclic imides
IE903410A1 (en) * 1989-10-09 1991-04-10 Novo Nordisk As Indole derivatives, their preparation and use
US5272148A (en) * 1992-09-09 1993-12-21 Hoechst-Roussel Pharmaceuticals Incorporated Heteroarenylpiperazines
FR2738822B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 4-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)quinolein-2(1h)-one, leur preparation et leur application en therapeutique
SI0850235T1 (en) * 1995-09-15 2000-04-30 Sanofi-Synthelabo Quinolein-2(1h)-one derivatives as serotonin antagonists
FR2738824B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 3-(omega(4-(thieno(3,2-c)pyridin-4-yl)piperazin-1 -yl)alkyl)-3,4-dihydroquinazolin-2(1h)-one,leur preparation et leur application en therapeutique
FR2738823B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 3-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)-3,4-dihydroquinolein-2(1h)-one,leur preparation et leur application en therapeutique
FR2761071B1 (fr) * 1997-03-20 1999-12-03 Synthelabo Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique
FR2797874B1 (fr) * 1999-08-27 2002-03-29 Adir Nouveaux derives de la pyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20040077605A1 (en) 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4361565A (en) * 1981-12-28 1982-11-30 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines

Also Published As

Publication number Publication date
ES554659A0 (es) 1987-12-16
FI85484B (fi) 1992-01-15
GB2174703A (en) 1986-11-12
ZA862046B (en) 1986-11-26
GR861149B (en) 1986-09-09
AU593244B2 (en) 1990-02-08
AU5679586A (en) 1986-11-13
ES557855A0 (es) 1989-05-16
GB8610810D0 (en) 1986-06-11
KR860009008A (ko) 1986-12-19
MY100777A (en) 1991-02-14
PT82523B (pt) 1988-10-14
DK207186D0 (da) 1986-05-05
ES557839A0 (es) 1989-01-16
CN86103071A (zh) 1987-03-18
CH672787A5 (es) 1989-12-29
EG18206A (en) 1992-09-30
IE861193L (en) 1986-11-06
ES8802614A1 (es) 1988-09-01
JPS61268681A (ja) 1986-11-28
GB2174703B (en) 1988-10-26
IE59201B1 (en) 1994-01-26
FI85484C (fi) 1992-04-27
LU86421A1 (fr) 1986-12-05
ES557809A0 (es) 1988-09-01
DK165745B (da) 1993-01-11
KR940000829B1 (ko) 1994-02-02
IT1208607B (it) 1989-07-10
DE3615180C2 (de) 1996-03-07
DK165745C (da) 1993-06-14
HUT43848A (en) 1987-12-28
IT8620313A0 (it) 1986-05-06
HU195509B (en) 1988-05-30
ES8900138A1 (es) 1989-01-16
SE8602061D0 (sv) 1986-05-05
PT82523A (en) 1986-06-01
SE8602061L (sv) 1986-11-07
NL8601146A (nl) 1986-12-01
AT398572B (de) 1994-12-27
FR2581385B1 (fr) 1991-10-04
ES9000005A1 (es) 1989-11-01
DE3615180A1 (de) 1986-11-06
CA1278792C (en) 1991-01-08
ES8802149A1 (es) 1988-04-01
ES557757A0 (es) 1988-04-01
CN1017901B (zh) 1992-08-19
DK207186A (da) 1986-11-07
ES8801250A1 (es) 1987-12-16
FI861820A7 (fi) 1986-11-07
FR2581385A1 (fr) 1986-11-07
FI861820A0 (fi) 1986-04-30
SE465270B (sv) 1991-08-19
BE904724A (fr) 1986-11-05
JPH0753728B2 (ja) 1995-06-07
ATA121486A (de) 1994-05-15

Similar Documents

Publication Publication Date Title
ES8802153A1 (es) Procedimiento para preparar derivados de isoxazol y furano.
ES2157224T3 (es) Derivados de 5-arilindol y su uso como agonistas de serotonina (5-ht 1).
PE11898A1 (es) Nuevos inhibidores de la farnesiltransferasa, su preparacion y los compuestos farmaceuticos que los contienen
ES2067744T3 (es) Aminas heterociclicas con actividad sobre el sistema nervioso central.
ES2174836T3 (es) Heterrociclos nitrogenados triciclicos condesados como antagonistas de receptor de la sustancia p.
ES2052675T3 (es) 3-(4-piperazinil-sustituido en 1)butil)-4-tiazolidinonas, un procedimiento para su preparacion y su uso como medicamentos.
ES2189820T3 (es) Nuevos derivados de eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
ES8702787A1 (es) Procedimiento para preparar nuevos tetrahidro-benzotiazoles.
ES2118283T3 (es) Derivados de acidos benzofuranil- y -tiofenil-alcanocarboxilicos.
ES2067500T3 (es) 1-indolilalquil-4-(piridinil-sustituidas)piperazinas.
ES2071666T3 (es) Derivados de pirazoloisoquinolina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES9000005A1 (es) Un procedimiento para la preparacion de derivados de piperazinilo 1,4-disustituidos
SE8304006D0 (sv) Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
ATE27160T1 (de) Tri- und tetracyclische imidazo(1,5a)(1,4)benzodiazepin-1-carbonsaeurederivate.
ES2139965T3 (es) Benzoilguanidinas sustituidas con grupos de caracter basico, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
ES8801211A1 (es) Un procedimiento para preparar derivados de quinolona
ES2031894T3 (es) Procedimiento para preparar derivados de 4(3h)-oxo-5,6,7,8-tetrahidropirido-(2,3-d)-pirimidina.
ES2040856T3 (es) Un procedimiento para preparar un compuesto de tiofeno.
ES2143675T3 (es) Bencenosulfonil-ureas-tioureas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
ES2104370T3 (es) Derivados de (arilalquilaminobencil)aminopropionamidas sustituidas, su preparacion y utilizacion.
ES2038708T3 (es) Metodo para producir compuestos de benzotiepino(5,4-c)piridazina.
FR2449677B1 (fr) Nouveaux derives de benzoyl-2 glycylanilides substitues, leur preparation et leur application en tant que medicaments anxiolytiques
ES2155546T3 (es) Bencenosulfonil-ureas y -tioureas sustituidas, procedimiento para su preparacion y el uso de preparaciones farmaceuticas basadas en estos compuestos, asi como medicamentos que los contienen.
ES2104987T3 (es) Derivados de eteres milbemicina, su preparacion y su aplicacion terapeutica y agroquimica.
ES2159943T3 (es) Neuvos derivados de piridina y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20060307